Surrogate Endpoint
What Is Accelerated Approval? The FDA Pathway That Gets Drugs to Patients Faster
Accelerated Approval is one of the FDA’s most powerful and most debated regulatory tools. It allows drugs to be approved and reach patients before the company has generated the full clinical evidence that would normally be required — based on the premise that for serious conditions with unmet needs, earlier access to a promising therapy…
